Discovery of selective phosphonamide-based inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)

Bioorg Med Chem Lett. 2003 Jun 16;13(12):2021-4. doi: 10.1016/s0960-894x(03)00292-0.

Abstract

A novel series of phosphonamide-based inhibitors of tumor necrosis factor-alpha converting enzyme (TACE) was discovered by structural modification of tetrahydroisoquinoline derivative 1b, which was extremely weak inhibitor of TACE. (S)-Isomer at the phosphorus atom (7b) displayed potent inhibition for TACE, while selectivity sparing MMP-1, -3, and -9.

MeSH terms

  • ADAM Proteins
  • ADAM17 Protein
  • Amides / chemistry*
  • Amides / pharmacology*
  • Binding Sites
  • Drug Design
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology
  • Isomerism
  • Matrix Metalloproteinase Inhibitors
  • Matrix Metalloproteinases / metabolism
  • Metalloendopeptidases / antagonists & inhibitors*
  • Models, Molecular
  • Organophosphonates / chemistry*
  • Organophosphonates / pharmacology*
  • Structure-Activity Relationship

Substances

  • Amides
  • Enzyme Inhibitors
  • Matrix Metalloproteinase Inhibitors
  • Organophosphonates
  • ADAM Proteins
  • Matrix Metalloproteinases
  • Metalloendopeptidases
  • ADAM17 Protein